SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-007853
Filing Date
2022-03-01
Accepted
2022-03-01 06:30:48
Documents
69
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-10k_20211231.htm   iXBRL 10-K 2766235
2 EX-4.4 nerv-ex44_8.htm EX-4.4 16846
3 EX-21.1 nerv-ex211_9.htm EX-21.1 3822
4 EX-23.1 nerv-ex231_6.htm EX-23.1 2404
5 EX-31.1 nerv-ex311_7.htm EX-31.1 16391
6 EX-31.2 nerv-ex312_10.htm EX-31.2 16149
7 EX-32.1 nerv-ex321_11.htm EX-32.1 8740
  Complete submission text file 0001564590-22-007853.txt   8276779

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nerv-20211231.xsd EX-101.SCH 51419
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20211231_cal.xml EX-101.CAL 55618
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20211231_def.xml EX-101.DEF 180661
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20211231_lab.xml EX-101.LAB 430157
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20211231_pre.xml EX-101.PRE 340257
63 EXTRACTED XBRL INSTANCE DOCUMENT nerv-10k_20211231_htm.xml XML 1204453
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 22693829
SIC: 2834 Pharmaceutical Preparations